Showing results (281-290 of 529) with videos related to

Sort By:
Pageof 53
Cancer Biology & Therapy|May 16, 2019
Management of giant cell hepatitis associated with chronic lymphocytic leukemia - a case series and review of the literatureJoanna M Rhodes, Stephen J Schuster, Emma E Furth, et al.
Leukemia & Lymphoma|August 20, 2005
Regression of pulmonary MALT lymphoma after treatment with rituximabElise A Chong, Jakub Svoboda, Sindhu Cherian, et al.
Blood Advances|October 18, 2023
TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current eraDaniel J Landsburg, Jennifer Jd Morrissette, Sunita D Nasta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2002
High rate of invasive fungal infections following nonmyeloablative allogeneic transplantationElisabeth A Hagen, Hillary Stern, David Porter, et al.
Journal of Biomedical Optics|March 25, 2014
Porcine skin damage thresholds for 0.6 to 9.5 cm beam diameters from 1070-nm continuous-wave infrared laser radiationRebecca Vincelette, Gary D Noojin, Corey A Harbert, et al.
Clinical Lymphoma|November 15, 2001
Progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with monoclonal antibody therapyD E Tsai, S J Schuster, A Matthies, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 26, 2019
Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma With Venetoclax: A Single-Center Evaluation of Off-Label UseMitchell E Hughes, Daniel J Landsburg, Daniel J Rubin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2015
Combination of Lenalidomide and Rituximab Overcomes Rituximab Resistance in Patients with Indolent B-cell and Mantle Cell LymphomasElise A Chong, Tahamtan Ahmadi, Nicole A Aqui, et al.
European Journal of Neurology|April 9, 2025
Alterations of Fat and Ketone Body Metabolism in ALS and SMA-A Prospective Observational StudyC Herrmann, Z Uzelac, S Michels, et al.
Blood Advances|April 10, 2020
Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trialRichard T Maziarz, Stephen J Schuster, Vadim V Romanov, et al.
Pageof 53